Pharmaceutical company AstraZeneca says it is buying U.S. drug developer Alexion in a deal worth $39 billion.from Top Business News- News18.com https://ift.tt/37e6RzT
AstraZeneca Buying Drug Developer Alexion For $39 Billion
Pharmaceutical company AstraZeneca says it is buying U.S. drug developer Alexion in a deal worth $39 billion.from Top Business News- News18.com https://ift.tt/37e6RzT
Related Posts
Walmart Sacks Around 50 Executives From Real Estate Division in India: Report
Aramco's 'Greenshoe Option' Pushes IPO to Record $29.4 Billion
Infosys Shares Climb Over 4% After Brokerages Give Thumbs Up to Q3 Results
India is in Talks with Mongolia and Russia for Importing Coking Coal: Dharmendra Pradhan
Sensex Hits Lifetime High, Zooms Over 250 Points; Infosys Leads Gains at 4%
0 comments: